The potential clinical utility of serum α-protryptase levels

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 6, 1999, Pages 1092-1099

  Kanthawatana, Sukanya ^a   Carias, Katherine ^a   Arnaout, Rand ^a   Hu, Jiang ^a   Irani, Anne Marie A ^a   Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Anaphylaxis; Mast cell; Mastocytosis; Tryptase

Indexed keywords

ALPHA PROTRYPTASE; TRYPTASE; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ARTICLE; AUTOPSY; BIOPSY; CELL HYPERPLASIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS;

EID: 0032837483     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70184-3     Document Type: Article

References (34)

1. 1. Schwartz LB. Tryptase: a mast cell serine protease. Methods Enzymol 1994;244:88-100.
2. 2. Schwartz LB, Lewis RA, Seidin D, Austen KF. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol 1981;126:1290-4.
3. 3. Schwartz LB, Lewis RA, Austen KF. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem 1981;256:11939-43.
4. 4. Schwartz LB, Sakai K, Bradford TR, Ren SL, Zweiman B, Worobec AS, Metcalfe DD. The α form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995;96:2702-10.
5. 5. Enander I, Matsson P, Nystrand J, Andersson A-S, Eklund E, Bradford TR, et al. A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. J Immunol Methods 1991;138:39-46.
6. 6. Schwartz LB, Bradford TR, Rouse C, Irani A-M, Rasp G. Van der Zwan JK, et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 1994;14:190-204.
7. 7. Van der Linden P-WG, Hack CE, Poortman J, Vivié-Kipp YC, Struyvenberg A, Van der Zwan JK. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 1992;90:110-8.
8. 8. Schwartz LB, Yunginger JW, Miller JS, Bokhari R, Dull D. The time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989;83:1551-5.
9. 9. Kettelhut BV, Parker RI, Travis WD, Metcalfe DD. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis: a study of 17 patients. Am J Clin Pathol 1989;91:558-62.
10. 10. Travis WD, Li C-Y, Bergstralh EJ, Yam LT, Swee RG. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore) 1988;67:345-68.
11. 11. Horny HP, Sillaber C, Menke D, Kaiserling E, Wehrmann M, Stehberger B, et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 1998;22:1132-40.
12. 12. Caslells MC, Irani AM, Schwartz LB. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 1987;138:2184-9.
13. 13. Xia H-Z, Kepley CL, Sakai K, Chelliah J, Irani A-MA, Schwartz LB. Quantitation of tryptase, chymase, FcεRIα, and FcεRIγ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 1995;154:5472-80.
14. 14. Nagata H, Worobec AS, Oh CK, Tannenbaum S, Suzuki Y, Metcalfe DD. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci 1995;92:10560-4.
15. 15. Nagata H, Worobec AS, Semere T, Metcalfe DD. Elevated expression of the proto-oncogene c-kit in patients with mastocytosis. Leukemia 1998;12:175-81.
16. 16. Shah PY, Sharma V, Worobec AS, Metcalfe DD, Zwick DC. Congenital bullous mastocytosis with myeloproliferative disorder and c-kit mutation. J Am Acad Dermatol 1998;39:119-21.
17. 17. Nagata H, Okada T, Worobec AS, Semere T, Metcalfe DD. c-kit mutation in a population of patients with mastocytosis. Int Arch Allergy Immunol 1997;113:184-6.
18. 18. Kitayama H, Tsujimura T, Matsumura I, Oritani K, Ikeda H, Ishikawa J, et al. Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood 1996;88:995-1004.
19. 19. Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, et al. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996;183:2681-6.
20. 20. Castleman WL, Owens SB, Brundage-Anguish LJ. Acute and persistent alterations in pulmonary inflammatory cells and airway mast cells induced by Sendai virus infection in neonatal rats [published erratum appears in Vet Pathol 1989;26:187]. Vet Pathol 1989;26:18-25.
21. 21. Castleman WL, Sorkness RL, Lemanske RF Jr, McAllister PK. Viral bronchiolitis during early life induces increased numbers of bronchiolar mast cells and airway hyperresponsiveness. Am J Pathol 1990;137:821-31.
22. 22. Sorden SD, Castleman WL. Virus-induced increases in bronchiolar mast cells in Brown Norway rats are associated with both local mast cell proliferation and increases in blood mast cell precursors. Lab Invest 1995;73:197-204.
23. 23. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993;92:1736-44.
24. 24. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, et al. Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995;92:10560-4.
25. 25. Kors JW, van Doormaal JJ, de Monchy JGR. Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis. J Intern Med 1993;233:255-8.
26. 26. Fricker M, Helbling A, Schwartz L, Muller U. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol 1997;100:11-5.
27. 27. Yunginger JW, Nelson DR, Squillace DL, Jones RT, Holley KE, Hyma BA, et al. Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 1991;36:857-65.
28. 28. Ansari MQ, Zamora JL, Lipscomb MF. Postmortem diagnosis of acute anaphylaxis by serum tryptase analysis: a case report. Am J Clin Pathol 1993;99:101-3.
29. 29. Edston E, Van Hage-Hamsten M. β-tryptase measurements post-mortem in anaphylactic deaths and in controls. Forensic Sci Int 1998;93:135-42.
30. 30. Randall B, Butts J, Halsey JF. Elevated postmortem tryptase in the absence of anaphylaxis. J Forensic Sci 1995;40:208-11.
31. 31. Schwartz HJ, Yunginger JW, Schwartz LB. Is unrecognized anaphylaxis a cause of sudden unexpected death? Clin Exp Allergy 1995;25:866-70.
32. 32. Holgate ST, Walters C, Walls AF, Lawrence S, Shell DJ, Variend S, et al. The anaphylaxis hypothesis of sudden infant death syndrome (SIDS): mast cell degranulation in cot death revealed by elevated concentrations of tryptase in serum. Clin Exp Allergy 1994;24:1115-22.
33. 33. Platt MS, Yunginger JW, Sekula-Perlman A, Irani A-MA, Smialek J, Mirchandani HG, et al. Involvement of mast cells in sudden infant death syndrome. J Allergy Clin Immunol 1994;94:250-6.
34. 34. Hagan LL, Goetz DW, Revercomb CH, Garriott J. Sudden infant death syndrome: a search for allergen hypersensitivity. Ann Allergy Asthma Immunol 1998;80:227-31.